NOP RECEPTOR MEDIATES ANTI-ANALGESIA INDUCED BY AGONIST-ANTAGONIST OPIOIDSGEAR, R. W; BOGEN, O; FERRARI, L. F et al.Neuroscience. 2014, Vol 257, pp 139-148, issn 0306-4522, 10 p.Article

Intravenous nalbuphine 50 μg·kg^-1 is ineffective for opioid-induced pruritus in pediatricsNAKATSUKA, Nao; MINOGUE, Scan C; KINGSLEY, Justin et al.Canadian journal of anaesthesia. 2006, Vol 53, Num 11, pp 1103-1110, issn 0832-610X, 8 p.Article

Population pharmacokinetics of nalbuphine after surgery in childrenBRESSOLLE, F; KHIER, S; ROCHETTE, A et al.British journal of anaesthesia. 2011, Vol 106, Num 4, pp 558-565, issn 0007-0912, 8 p.Article

Utilisation des antalgiques de palier II chez l'enfant = Use of level 2 analgesics in childDUBRAY, C.Douleur et analgésie. 1998, Vol 11, Num 4, pp 185-188, issn 1011-288XArticle

Comparison of nalbuphine and buprenorphine in total intravenous anaesthesiaKHAN, F. A; ZAIDI, A; KAMAL, R. S et al.Anaesthesia. 1997, Vol 52, Num 11, pp 1095-1101, issn 0003-2409Article

Nalbuphine-induced psychosis treated with naloxoneSIEMIANOWSKI, Laura A; ROSENHECK, Justin P; WHITMAN, Craig B et al.American journal of health-system pharmacy. 2014, Vol 71, Num 9, pp 717-721, issn 1079-2082, 5 p.Article

Prevention of emergence agitation after sevoflurane anesthesia for pediatric cerebral magnetic resonance imaging by small doses of ketamine or nalbuphine administered just before discontinuing anesthesiaDALENS, Bernard J; PINARD, Anne Marie; LETOURNEAU, Dany-Roch et al.Anesthesia and analgesia. 2006, Vol 102, Num 4, pp 1056-1061, issn 0003-2999, 6 p.Article

Chronic sucrose ingestion enhances mu-opioid discriminative stimulus effectsJEWETT, David C; GRACE, Martha K; LEVINE, Allen S et al.Brain research. 2005, Vol 1050, Num 1-2, pp 48-52, issn 0006-8993, 5 p.Article

A review of emergency equipment carried and procedures performed by UK front line paramedicsROBERTS, Keith; ALLISON, K. P; PORTER, K. M et al.Resuscitation. 2003, Vol 58, Num 2, pp 153-158, issn 0300-9572, 6 p.Article

Response of neuropathic trigeminal pain to the combination of low-dose nalbuphine plus naloxone in humansSCHMIDT, Brian L; GEAR, Robert W; LEVINE, Jon D et al.Neuroscience letters. 2003, Vol 343, Num 2, pp 144-146, issn 0304-3940, 3 p.Article

Differences in systemic opioid use do not explain increased fever incidence in parturients receiving epidural analgesiaGROSS, Jeffrey B; COHEN, Amy P; LANG, Janet M et al.Anesthesiology (Philadelphia). 2002, Vol 97, Num 1, pp 157-161, issn 0003-3022Article

Subjective, psychomotor, and physiological effects of cumulative doses of mixed-action opioids in healthy volunteersWALKER, Diana J; ZACNY, James P; GALVA, Kimberly E et al.Psychopharmacologia. 2001, Vol 155, Num 4, pp 362-371, issn 0033-3158Article

Improvement of nalbuphine bioavailability through rectal administration of a prodrugCHANG, R.-K; HUSSAIN, M. A.Pharmaceutical development and technology. 1998, Vol 3, Num 1, pp 131-134, issn 1083-7450Article

Patient-controlled epidural analgesia : Interactions between nalbuphine and hydromorphonePARKER, R. K; HOLTMANN, B; WHITE, P. F et al.Anesthesia and analgesia. 1997, Vol 84, Num 4, pp 757-763, issn 0003-2999Article

Tolerance and cross-tolerance to morphine-like stimulus effects of μ opioids in ratsWALKER, E. A; RICHARDSON, T. M; YOUNG, A. M et al.Psychopharmacologia. 1997, Vol 133, Num 1, pp 17-28, issn 0033-3158Article

Applications cliniques de la nalbuphine = Clinical applications of nalbulphineALIBEU, J.-P.Douleur et analgésie. 1997, Vol 10, Num 4, pp 139-146, issn 1011-288XArticle

Discriminative stimulus and subjective effects of opioids with mu and kappa activity : data from laboratory animals and human subjectsDYKSTRA, L. A; PRESTON, K. L; BIGELOW, G. E et al.Psychopharmacologia. 1997, Vol 130, Num 1, pp 14-27, issn 0033-3158Article

Equal volumes of undiluted nalbuphine and lidocaine and normal diluted saline prevents nalbuphine-induced injection painWANG, Fu-Yuan; SHEN, Ya-Chun; CHEN, Mao-Kai et al.Acta anaesthesiologica taiwanica (Print). 2011, Vol 49, Num 4, pp 125-129, issn 1875-4597, 5 p.Article

Temperature-sensitive hydrogels composed of chitosan and hyaluronic acid as injectable carriers for drug deliveryFANG, Jia-You; CHEN, Jyh-Ping; LEU, Yann-Lii et al.European journal of pharmaceutics and biopharmaceutics. 2008, Vol 68, Num 3, pp 626-636, issn 0939-6411, 11 p.Article

Hair analysis by LC-MS as evidence of nalbuphine abuse by a nurseKLINZIG, F; VINNER, E; BRASSART, C et al.Journal of analytical toxicology. 2007, Vol 31, Num 1, pp 62-65, issn 0146-4760, 4 p.Article

Excretion of Ketoprofen and Nalbuphine in Human Milk During Treatment of Maternal Pain After DeliveryJACQZ-AIGRAIN, Evelyne; SERREAU, Raphael; BOISSINOT, Christine et al.Therapeutic drug monitoring. 2007, Vol 29, Num 6, pp 815-818, issn 0163-4356, 4 p.Article

Souffrance morale : cas d'un mésusage de nalbuphine mis en évidence par l'analyse de cheveux = Nalbuphine, or how to relieve a mental suffering. Misuse revealed by hair analysisVINNER, Elisabeth; KLINZIG, Florian; BRASSART, Claudie et al.Annales de toxicologie analytique. 2006, Vol 18, Num 1, pp 85-91, issn 0768-598X, 7 p.Article

Nalbuphine is effective in decreasing the rewarding effect induced by morphine in ratsTAO, Pao-Luh; LIANG, Kai-Wen; SUNG, Wen-Yi et al.Drug and alcohol dependence. 2006, Vol 84, Num 2, pp 175-181, issn 0376-8716, 7 p.Article

Antinociceptive effect of a novel long-acting nalbuphine preparationLIU, K. S; HU, O. Y. P; HO, S. T et al.British Journal of Anaesthesia. 2004, Vol 92, Num 5, pp 712-715, issn 0007-0912, 4 p.Article

Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedureOLIVETO, Alison; SEVARINO, Kevin; MCCANCE-KATZ, Elinore et al.Pharmacology, biochemistry and behavior. 2002, Vol 71, Num 1-2, pp 85-96, issn 0091-3057Article